HONG KONG October 5-9, 2018 Parkinson's Disease and Movement Disorders - Preliminary Program - Movement Disorder Society
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Preliminary Program
International Congress of
Parkinson’s Disease and Movement Disorders®
October 5-9, 2018
HONG KONG
www.mdscongress.org
International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Table of Contents
Invitation Letter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
About MDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
International Congress Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Congress Events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
CME Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Program at a Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Session Definitions/Faculty Roles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Daily Schedule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Friday, October 5, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Saturday, October 6, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Sunday, October 7, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Monday, October 8, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Tuesday, October 9, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Membership Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2 October 5-9, 2018 • HONG KONG • www.mdscongress.org
International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Welcome
Dear Colleagues,
On behalf of the International Parkinson and Movement Disorder Society (MDS), we are pleased to formally invite you to attend the International Congress of
Parkinson’s Disease and Movement Disorders ® in Hong Kong from October 5-9, 2018.
Hong Kong has a reputation of being a city of charm with a mix of tradition, cultural diversity and sophistication. It offers spectacular scenery and a skyline that has
been regarded as the biggest visual impact of all world cities.
Each year, the International Congress attracts delegates from around the world who come to learn about the latest research and perspectives, to listen to world
renowned speakers, and to be exposed to the most up-to-date information in the field of Movement Disorders. Once again, this year’s International Congress
promises to bring new ideas and unparalleled networking opportunities.
We look forward to welcoming you to Hong Kong and hope you will take advantage of the many exciting, educational opportunities the 2018 International Congress
offers.
With kind regards,
Christopher Goetz Buz Jinnah
President, International Parkinson and Movement Disorder Society, 2017-2019 Chair, Congress Scientific Program Committee, 2017-2019
Beomseok Jeon Vincent Mok
Co-Chair, Congress Scientific Program Committee, 2018 Co-Chair, Congress Scientific Program Committee, 2018
October 5-9, 2018 • HONG KONG • www.mdscongress.org 3
International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
About MDS
The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals who are
interested in Parkinson’s disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone
and motor control.
PURPOSE, MISSION AND GOALS
Purpose: To promote research into causes, prevention and treatment of Movement
The objective and mission of the Society shall be to advance the neurological Disorders by:
sciences pertaining to Movement Disorders; to improve the diagnosis and • Using the Society’s influence and resources to enhance support for research
treatment of patients; to operate exclusively for scientific, scholarly and • Facilitating the dissemination of information about research
educational purposes; to encourage research; to provide forums, such as medical • Encouraging the training of basic and clinical scientists in Movement
journals, scientific symposia and International Congresses, for sharing ideas and Disorders and related disorders
for advancing the related clinical and scientific disciplines; to encourage interest For the purposes of favorably affecting the care of patients with Movement
and participation in the activities of the Society among healthcare and allied Disorders, the Society will provide expertise, advice and guidance to:
professionals and scientists; and to collaborate with other related professional • Regulatory agencies to assist them in the approval process of safe and
and lay organizations. effective therapeutic interventions
Mission and Goals: • The public (media) and patient support groups by informing them of new
To disseminate knowledge about Movement Disorders by: research and therapeutic advances
• Providing educational programs for clinicians, scientists and the general • Governments to assist them in the development of policies that affect
public designed to advance scientific and clinical knowledge about support of research and patient care
Movement Disorders • Educational efforts to assist in developing standards of training in the
• Sponsoring International Congresses and Symposia on Movement specialty
Disorders
• Collaborating with other international organizations and lay groups
• Publishing journals, videotapes and other collateral materials committed
to high scientific standards and peer review
MDS OFFICERS (2017-2019)
President Secretary Treasurer Past-President
Christopher Goetz, USA Susan Fox, Canada Victor Fung, Australia Oscar Gershanik, Argentina
President-Elect Secretary-Elect Treasurer-Elect
Claudia Trenkwalder, Germany Bastiaan Bloem, Netherlands Louis Tan, Singapore
4 October 5-9, 2018 • HONG KONG • www.mdscongress.org
International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
About MDS
MDS INTERNATIONAL CONGRESS SCIENTIFIC PAST-PRESIDENTS
EXECUTIVE COMMITTEE PROGRAM COMMITTEE 2015-2017 Oscar Gershanik, Argentina
Charles Adler, USA Chair: Hyder Jinnah, USA 2013-2015 Matthew Stern, USA
Daniela Berg, Germany Co-Chair: Beomseok Jeon, South Korea 2011-2013 Günther Deuschl, Germany
Shengdi Chen, People’s Republic of China Co-Chair: Vincent Mok, Hong Kong 2009-2011 Philip Thompson, Australia
Carlos Cosentino, Peru Roongroj Bhidayasiri, Thailand 2007-2009 Anthony Lang, Canada
Jeffrey Kordower, USA Vincenzo Bonifaati, Netherlands 2005-2006 Andrew Lees, United Kingdom
Joaquim Ferreira, Portugal M. Angela Cenci Nilsson, Sweden 2003-2004 C. Warren Olanow, USA
D. James Surmeier, USA Shengdi Chen, People’s Republic of China 2001-2002 Werner Poewe, Austria
Ryosuke Takahashi, Japan Jean-Christophe Corvol, France 1999-2000 Mark Hallett, USA
Pille Taba, Estonia Steven Frucht, USA 1997-1998 Eduardo Tolosa, Spain
Mayela Rodriguez Violante, Mexico Emilia Gatto, Argentina 1995-1996 Joseph Jankovic, USA
Christopher Goetz, USA 1991-1994 C. David Marsden, United Kingdom
Jennifer Goldman, USA 1988-1991 Stanley Fahn, USA
INTERNATIONAL CONGRESS
Etienne Hirsch, France
OVERSIGHT COMMITTEE
Roland Dominic Jamora, Philippines INTERNATIONAL MEDICAL
Chair: Matthew Stern, USA Han-Joon Kim, South Korea SOCIETY FOR MOTOR
Günther Deuschl, Germany Vladimir Kostic, Serbia
Victor Fung, Australia DISTURBANCES PAST-
Shen-Yang Lim, Malaysia
Oscar Gershanik, Argentina Irene Litvan, USA PRESIDENTS
Christopher Goetz, USA Karen Marder, USA 1993-1994 C. Warren Olanow, USA
Beomseok Jeon, South Korea Wassilios Meissner, France 1991-1992 Bastian Conrad, Germany
Hyder Jinnah, USA Elena Moro, France 1989-1990 Mark Hallett, USA
Vincent Mok, Hong Kong Alice Nieuwboer, Belgium 1987-1988 Mario Manfredi, Italy
Claudia Trenkwalder, Germany Maria Stamelou, Greece 1985-1986 C. David Marsden, United Kingdom
Matthew Stern, USA
CONGRESS LOCAL Antonio Strafella, Canada MDS INTERNATIONAL
ORGANIZING COMMITTEE Carolyn Sue, Australia
SECRETARIAT
Ryosuke Takahashi, Japan
Chair: Vincent CT Mok Helio Teive, Brazil International Parkinson and Movement Disorder
Mandy Au Yeung Claudia Trenkwalder, Germany Society
Anne Yin Yan Chan 555 East Wells Street, Suite 1100
Danny TM Chan Milwaukee, WI 53202-3823 USA
Germaine Hiu Fai Chan Tel: +1 414-276-2145
Nelson Yuk-Fai Cheung Fax: +1 414-276-3349
Ya Ke E-mail: info@movementdisorders.org
Claire Ka Yee Lau Website: www.movementdisorders.org
Michael WY Lee
Margaret KY Mak
Shirley YY Pang
Tak Lap Poon
Kin Lun Tsang
Jonas Yeung
Helen LK Yip
Ken KL Yung
Barong Zhang
Xian Lun Zhu
October 5-9, 2018 • HONG KONG • www.mdscongress.org 5
International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
International Congress Information
Official Language Fees (in USD):
The official language of the 2018 International Congress is English. On or before From August 3 From September 6
August 2, 2018 – September 5, 2018 – October 9, 2018
Venue
MDS Member $600 $650 $700
Hong Kong Convention and Exhibition Centre
Non-Member $800 $850 $900
1 Expo Drive, Wan Chai
Hong Kong Junior Member/ $350 $375 $400
Participant*
Exhibition Health $350 $375 $400
Manufacturers, distributors and suppliers of products and services for physicians Professional
and researchers involved with Movement Disorders are invited to participate in the (Non-Physician)
International Congress exhibition. To receive a copy of the Exhibitor Prospectus, The International Congress registration fee includes admission to all scientific
please contact the MDS International Secretariat at sessions, Exhibit Hall and Poster Hall, a meeting bag and documentation. The
congress@movementdisorders.org or visit the International Congress website at registration fee excludes travel and accommodations.
www.mdscongress.org/Congress-2018/Sponsor-Exhibit.htm. The exhibition is
open to all registered delegates. *Junior Members of MDS, those born after January 1, 1988, residents, fellows
and those still in training. Please fax or e-mail a copy of an official document
Abstract Poster Information indicating age or a letter from your employer stating training status to be
eligible for this discount. Without documentation, the delegate will be charged
Poster Sessions will be featured Saturday through Monday during the the non-member rate (Fax: +1 514-289-9844 or e-mail:
International Congress to ensure delegates are given the opportunity to review mdscongress@showcare.com within one week of submitting registration.)
as many abstracts as possible. Please visit
www.mdscongress.org/Congress-2018/Abstracts.htm for a detailed poster
schedule, including information about the Guided Poster Tours.
6 October 5-9, 2018 • HONG KONG • www.mdscongress.org
International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
International Congress Information
Registration Confirmation Scientific Sessions
Attendees who register online will receive a confirmation message immediately. The 2018 Scientific Program will incorporate Therapeutic Plenary Sessions,
Please present this confirmation at the International Congress registration desk Plenary and Parallel Sessions, Teaching Courses, Video Sessions, Skills
in Hong Kong to receive your registration materials. Workshops, Guided Poster Tours and Blue Ribbon Highlights.
Sessions will focus on the latest developments in:
Cancellation/Refund Policy • Technology in the Diagnosis, Monitoring, and Management of Movement
All cancellations must be requested in writing. Disorders
• Up to September 5, 2018 (pre-registration deadline): 100% refund, minus • Movement Disorder topics, including, but not limited to, ataxia, chorea,
a $75 administrative charge dystonia, myoclonus, Parkinson’s disease, restless legs syndrome,
• From September 6 – September 20, 2018: 50% refund spasticity, stereotypies, tics and tremors
• From September 21, 2018 onward: no refund • Basic Science issues, including, but not limited to, genetics, neuroimaging,
neuropharmacology, surgical therapy and transplantation
Group Registration • Other less common clinical conditions
Groups may be formed of six (6) or more delegates from the same company/
travel agency. Special Accessibility Needs
Group leaders will be able to continually make changes to the group up until the Delegates requiring special arrangements in order to fully participate in the
final pre-registration deadline of September 5, 2018. International Congress should provide a written description of such needs on
their registration form or send an e-mail to congress@movementdisorders.org.
Registration Desk To ensure appropriate accommodations, all special needs should be addressed in
advance with the MDS International Secretariat.
Name badge, scientific session tickets, Final Program, USB with full abstract list,
and International Congress bag can be collected at the International Congress Photography Policy
Registration Hall 3 FG Foyer during the following hours**:
Photography is not permitted in any of the 2018 International Congress scientific
Friday, October 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7:00 – 20:00 and/or educational sessions or in the poster areas.
Saturday, October 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7:00 – 18:00
Sunday, October 7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8:00 – 18:00
Monday, October 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8:00 – 18:00
Tuesday, October 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8:00 – 12:00
**Please note that these hours are subject to change. Please watch for updated
schedules at www.mdscongress.org and look for the schedule in the Final
Program.
October 5-9, 2018 • HONG KONG • www.mdscongress.org 7
International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
International Congress Events
Friday, October 5, 2018 Monday, October 8, 2018
Welcome Ceremony MDS Video Challenge
19:30 – 21:30 19:00 – 22:00
All International Congress attendees are warmly invited to attend the Please join Masters of Ceremony Anthony Lang and Kapil Sethi as they host a
International Congress Welcome Ceremony. This event is open to all registered world-renowned panel of Movement Disorders experts in guiding participants
delegates. through unique Movement Disorder cases. The cases will be presented by
representatives from Movement Disorder Centers around the world and
Sunday, October 7, 2018 discussed by the Panel of Experts. Awards will be given for the most interesting
and challenging cases. Country pride will add an enjoyable spirit of competition
Young Delegates Reception
to this event. The goal of this session is for attendees to learn from a series of
19:30 - 21:00
unusual, very interesting patients and see how senior experts approach these
At the Renaissance Hong Kong Harbour View Hotel, Oasis Room types of challenging cases.
Join your colleagues at the Renaissance on Sunday evening for a networking The Panel of Experts are:
event. Bettina Balint, United Kingdom
Orlando Barsottini, Brazil
Sun Ju Chung, South Korea
Mark Edwards, United Kingdom
Roberto Erro, Italy
This event is open to all registered delegates. For more information about the
MDS Video Challenge, please contact Sarah Smith at
congress@movementdisorders.org.
8 October 5-9, 2018 • HONG KONG • www.mdscongress.orgInternational Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
CME Information
Target Audience
Clinicians, researchers, post-doctoral fellows, medical residents, medical
students, allied health professionals with an interest in current clinical trends
and approaches for diagnosis and treatment of movement disorders.
Objectives
1) Evaluate the pharmacological and non-pharmacological management
options available for Parkinson’s disease and other movement disorders
2) Discuss the diagnostic approaches and tools available for Parkinson’s
disease and other movement disorders
3) Describe the pathogenesis and neurobiology of Parkinson’s disease and
other movement disorders
Satisfactory Completion
Participants must complete an evaluation to receive a certificate of continuing
medical education credit. Your chosen sessions must be attended in their
entirety. Partial credit of individual sessions is not available. If you are
seeking continuing education credit for a specialty not listed below, it is your
responsibility to contact your licensing/certification board to determine course
eligibility for your board requirement.
Accreditation Statement
In support of improving patient care, this activity has been planned and
implemented by Amedco and International Parkinson and Movement Disorder
Society. Amedco is jointly accredited by the American Council for Continuing
Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.
Credit Designation Statement
Amedco designates this live activity for a maximum of 29.50 AMA PRA Category
1 CreditsTM. Physicians should claim only the credit commensurate with the
extent of their participation in the activity.
October 5-9, 2018 • HONG KONG • www.mdscongress.org 9International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
International Congress Schedule-at-a-Glance
Friday, October 5 Saturday, October 6 Sunday, October 7 Monday, October 8 Tuesday, October 9
8:00
8:30 Plenary Session Plenary Session Plenary Session
Plenary Session
Therapeutic Plenary Session 8:00 - 9:30 8:00 - 9:30 8:00 - 9:30
(Presidential Lectures)
9:00 8:00 -10:00
8:00 - 10:00
9:30 Break Break
MDS
Break 9:30 - 10:00 9:30 - 10:00
Business Meeting
10:00 Break 9:30 - 10:30
9:30 - 10:30
Regional Assemblies 10:00 - 10:30 Controversies
10:30 10:00-11:00 10:00 - 11:00
Plenary Session
11:00 10:00 - 12:00
Plenary Session
Plenary Session Blue Ribbon Highlights
(Grand Rounds)
11:30 10:30 - 12:30 11:00 - 12:00
10:30 - 12:30
Therapeutic Plenary Session
12:00 11:00 - 13:00 Break 12:00 - 12:15 End
12:30 Break 12:30 - 12:45 Break 12:30 - 12:45 Corporate Therapeutic Symposia
12:15 - 13:15
13:00 Corporate Therapeutic Symposia Corporate Therapeutic Symposia
Corporate 12:45 - 13:45 12:45 - 13:45
Break
13:30 Therapeutic
13:00 - 14:30 Break/ Guided Poster Tours/
Symposium
Poster Sessions
14:00 13:15 - 14:15
Break/ Guided Poster Tours/ Break/ Guided Poster Tours/ 13:15 - 14:45
Poster Sessions Poster Sessions
14:30
13:45 - 15:15 13:45 - 15:15
Break 14:45 - 15:00
15:00
Therapeutic Plenary Session Break 15:15 - 15:30 Break 15:15 - 15:30
15:30 14:30 - 16:30
Parallel Sessions/ Teaching Courses
16:00 15:00 - 17:00
Parallel Sessions/ Teaching Courses Parallel Sessions/ Teaching Courses
16:30 Break 15:30 - 17:30 15:30 - 17:30
16:30 - 17:00
17:00 Break
17:00 - 17:30
17:30 Break Break
Therapeutic Plenary Session 17:30 - 18:00 17:30 - 18:00
18:00 17:00 - 19:00 Skills Workshops/ Video Sessions
17:30 - 19:00
18:30 Skills Workshops/ Video Sessions Skills Workshops/ Video Sessions
18:00 - 19:30 18:00 - 19:30
19:00 Break
19:00 - 19:30
19:30
20:00 MDS Video Challenge
Welcome Ceremony 19:00 - 22:00
20:30 19:30 - 21:30
21:00
10 October 5-9, 2018 • HONG KONG • www.mdscongress.orgInternational Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
International Congress Session Definitions
Blue Ribbon Session: Skills Workshops:
This session provides a critical review of the best poster presentations by a panel These clinic-based training sessions provide an educational illustration of clinical
of experts, highlighting the relevance, novelty and quality of both clinical and techniques and treatment procedures through demonstrations utilizing patient
basic research presented by the delegates. videotapes and proper equipment to further develop practitioners’ skills and
knowledge within the field of treatment of movement disorders.
Controversies:
This Plenary Session is designed to involve all International Congress attendees. Teaching Courses:
Content is prepared to stimulate interest and debate among a panel of experts. These educational programs provide up-to-date information focused on a single
Views from several angles will be addressed as discussion of pre-selected “hot” topic. The sessions highlight both the clinical and basic science of topics of
topics will be open for debate among the panelists. relevance to Movement Disorder specialists. The sessions are unique in providing
a syllabus that includes a review of the topic and the presentation slides. In
Parallel Sessions: addition, these programs provide ample time for questions and a discussion
These concurrent sessions provide an in-depth report of the latest research period at the conclusion of the presentations.
findings, state-of-the-art treatment options, as well as a discussion of future
strategies. Parallel sessions will have evidence-based components and incorporate Therapeutic Plenary Sessions:
the “hot” issues in Parkinson’s disease and other movement disorders. These sessions provide the latest information regarding the scientific and
clinical evidence supporting treatment options for Parkinson’s disease and other
Plenary Sessions: movement disorders.
These sessions provide a broad overview of the latest clinical and basic science
research findings and state-of-the-art information. Video Sessions:
Designed to provide a broad overview of related movement disorders, the video
sessions will focus on the phenomenology covering the many different kinds of
movement disorders affecting the population today.
INTERNATIONAL CONGRESS NON-CME EDUCATIONAL SESSIONS
Corporate Therapeutic Symposia: MDS Video Challenge:
These company-based informational sessions provide attendees with non-CME The goal of this session is for attendees to learn from a series of unusual patients
educational opportunities to learn the latest in therapeutics. and observe how senior experts approach a challenging case. A world-renowned
panel of Movement Disorders experts guide attendees through these unique
Guided Poster Tours: Movement Disorder cases as they are presented by representatives from
Guided Poster Tours give small groups of delegates an opportunity to hear Movement Disorder Centers around the world.
discussion on a select group of abstracts in several sub-categories.
Poster Sessions:
Poster sessions give each delegate an opportunity to view their colleagues’ posters
on the most current research in the field of Movement Disorders. Authors are
present for 90 minutes each day to explain their work and answer questions.
INTERNATIONAL CONGRESS FACULTY ROLES
Speaker / Presenter: Creates and delivers the presentation materials, and participates in the dialogue of the session.
Chair: Facilitates the learnings of the session; ensures that learning objectives are met during the presentation(s), and engages the learners as needed.
Liaison: Develops the session from the onset and provides guidance to ensure that the overall objectives are met.
2018 INTERNATIONAL CONGRESS THEME
At each annual International Congress, the Congress Scientific Program Committee selects a theme that is highlighted throughout the meeting. This year’s
theme, Technology in the Diagnosis, Monitoring, and Management of Movement Disorders, will be showcased in two Plenary Sessions, six Parallel Sessions,
one Skills Workshop, one Teaching Course, and one Video Session. International experts will serve as faculty, and the meeting participants can elect to
attend any or all of these sessions. Themed sessions are designated in the program with .
October 5-9, 2018 • HONG KONG • www.mdscongress.org 11International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Friday, October 05, 2018
1101 Therapeutic Plenary Session 2. Recognize and apply botulinum toxin as a treatment 18:20 Current Trends and New
for dystonia and tremor Horizons in Neurosurgery for
Update on Management Movement Disorders
3. Evaluate and select candidates with dystonia and
Strategies for Parkinson’s tremor for surgical intervention Andres Lozano, Canada
Disease Recommended Audience: Basic scientists, Clinical academicians,
8:00 – 10:00 1103 Therapeutic Plenary Session Non-physician Health Professionals, Practitioners, Students/
Chairs: Shengdi Chen, People’s Republic of China Update on Management Residents/Trainees
Alice Nieuwboer, Belgium Strategies of Hyperkinetic At the conclusion of this session, participants should be
8:00 Early Pharmacologic Movement Disorders: Tics, better able to:
Management Myoclonus, and Restless 1. Summarize the current state of the art in the
Olivier Rascol, France Legs Syndrome treatment of movement disorders with DBS
8:40 Role of Rehabilitation and 14:30 – 16:30 2. Identify advantages and disadvantages of lesion-
Exercise based therapies for movement disorders
Chairs: Raymond Rosales, Philippines
Colleen Canning, Australia 3. Describe the most recent advances in DBS surgery for
Claudia Trenkwalder, Germany
9:20 Later Stage Parkinson’s Disease movement disorders
14:30 Update on the Management
Anthony Lang, Canada Strategy of Tics: Differential
Recommended Audience: Basic scientists, Clinical academicians, Diagnosis and New Therapeutic
Non-physician Health Professionals, Practitioners, Students/ Approaches
Residents/Trainees
Andreas Hartmann, France
At the conclusion of this session, participants should be 15:10 Update on the Management
better able to: Strategy of Myoclonus: Common
1. Discuss management in early Parkinson’s disease and Rare Causes and New
including potential disease modifying strategies Therapeutic Approaches
2. Review current role of rehabilitation and exercise Marina De Koning-Tijssen, Netherlands
including physical, occupational and speech therapies 15:50 Update on Restless Legs
3. Describe management strategies for advanced Syndrome: Pathophysiological
Parkinson’s disease, including invasive interventions Concepts and Evidenced Based
Therapy
1102 Therapeutic Plenary Session Juliane Winkelmann, Germany
Update on Management Recommended Audience: Basic scientists, Clinical academicians,
Non-physician Health Professionals, Students/Residents/Trainees
Strategies for Dystonia and
Tremor At the conclusion of this session, participants should be
11:00 – 13:00 better able to:
1. Describe the differential diagnosis of tic disorders and
Chairs: Marina De Koning-Tijssen, Netherlands
new treatment approaches
Jonas Hon Ming Yeung, Hong Kong
2. Explain common and rare causes of myoclonus and
11:00 Pharmacologic Management of options available for treatment
Dystonia and Tremor: An Under-
3. Outline the pathogenesis of restless legs syndrome
Utilized Approach?
and its evidenced based therapy
Tiago Mestre, Canada
11:40 Botulinum Toxin for Dystonia 1104 Therapeutic Plenary Session
and Tremor: Old Standards and Update on Neurosurgical
New Opportunities
Management of Movement
Raymond Rosales, Philippines
Disorders
12:20 Surgical Intervention for
Dystonia and Tremor: Past, 17:00 – 19:00
Present and Future Chairs: Günther Deuschl, Germany
Ritesh Ramdhani, USA Danny Chan, Hong Kong
Recommended Audience: Basic scientists, Clinical academicians, 17:00 Deep Brain Stimulation Surgery
Non-physician Health Professionals, Practitioners, Students/ for Movement Disorders: Where
Residents/Trainees Do We Stand
Patricia Limousin, United Kingdom
At the conclusion of this session, participants should be
better able to: 17:40 Current Role of Lesions in the
Management of Movement
1. Select a management strategy for pharmacologic
Disorders
treatment of dystonia and tremor
José Obeso, Spain
12 October 5-9, 2018 • HONG KONG • www.mdscongress.orgInternational Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Saturday, October 06, 2018
2101 Plenary Session 2203 Parallel Session At the conclusion of this session, participants should be
better able to:
Presidential Lectures Ethical Issues and Novel
1. Describe the rationale and current status of immune
8:00 – 10:00 Technologies for the therapy for Parkinson’s disease and other
Chairs: Christopher Goetz, USA Practicing Clinician neurodegenerative disorders that involve abnormal
Claudia Trenkwalder, Germany 15:30 – 17:30 protein accumulation
Stanley Fahn Lecture Award Chairs: Beomseok Jeon, South Korea 2. Describe the rationale and current status of novel
Recipient Kapil Sethi, USA genetic technologies for treatment of inherited
Marie Vidailhet, France 15:30 Ethical Issues in Movement neurological disorders
C. David Marsden Lecture Award Disorders 3. Describe the rationale and potential for modulating
Recipient Karen Rommelfanger, USA protein clearance mechanism such as autophagy for
Eng-King Tan, Singapore 16:10 Ethical Issues with Genetic treatment of Parkinson’s disease and related disorders
Recommended Audience: Basic scientists, Clinical academicians, Testing in the Next Generation involving abnormal protein accumulation
Non-physician Health Professionals, Practitioners, Students/ Sequencing Era
Residents/Trainees Christine Klein, Germany 2205 Parallel Session
16:50 The Role of the Clinician In the New Insights in Dystonia:
2102 Themed Plenary Session Era of Advanced Diagnostic Genetics, Anatomy, and
Modulation of Gene Testing
Neurophysiology
Expression and Beomseok Jeon, South Korea
15:30 – 17:30
Recommended Audience: Basic scientists, Clinical academicians,
Neurodegenerative Chairs: Mark Hallett, USA
Non-physician Health Professionals, Practitioners, Students/
Movement Disorders Residents/Trainees Hyder Jinnah, USA
10:30 – 12:30 15:30 Genetics
At the conclusion of this session, participants should be
Chairs: Christine Klein, Germany Katja Lohmann, Germany
better able to:
Baorong Zhang, People’s Republic of China 16:10 Neuroanatomical Perspective
1. Discuss basic ethical issues relevant to the
10:30 Overview of Epigenetics and Its management of patients with movement disorders Ellen Hess, USA
Impact on Neurodegeneration 16:50 Neurophysiology
2. Describe the ethical concerns with genetic testing in
Tiago Outeiro, Germany the next generation sequencing era Angelo Quartarone, Italy
11:10 Overview of Non-Coding Genetic 3. Describe the ethical concerns for advanced diagnostic Recommended Audience: Basic scientists, Clinical academicians
Elements and Their Impact on testing in the diagnosis and management of
Neurodegeneration At the conclusion of this session, participants should be
movement disorders
Menno Creyghton, Netherlands better able to:
11:50 Therapeutic Implications of 1. Summarize different genes that are relevant in
Epigenetic and Non-Coding
2204 Parallel Session dystonia
Modulatory Elements Novel Technology-Based 2. Describe anatomical and pathological findings
David Standaert, USA Therapies on the Horizon associated with dystonia
Recommended Audience: Basic scientists, Clinical academicians, 15:30 – 17:30 3. Identify physiological and network changes in the CNS
Non-physician Health Professionals, Practitioners, Students/ Chairs: Olivier Rascol, France associated with dystonia
Residents/Trainees David Standaert, USA
At the conclusion of this session, participants should be 15:30 Active and Passive Immunization
better able to: for Parkinson’s Disease and Other
1. Describe the basic principles of epigenetics and their Proteinopathies
possible implications for neurodegeneration Werner Poewe, Austria
(including pathogenesis, biomarkers, and therapeutic 16:10 Gene Editing and Gene Silencing
targets) for Huntington’s Disease and
2. Summarize current knowledge on the role of non- Other Genetic Disorders
coding genetic sequences in the pathogenesis of Don Cleveland, USA
Parkinson’s disease (cis-regulatory DNA elements, 16:50 Enhancing Clearance of
genetic enhancers, non-coding RNAs) Pathological Proteins in
3. Discuss the therapeutic potential of manipulating Parkinson’s Disease and Other
epigenetic mechanisms and non-coding genetic Proteinopathies
elements for neurodegenerative diseases Seung-Jae Lee, South Korea
Recommended Audience: Basic scientists, Clinical academicians,
Practitioners, Students/Residents/Trainees
October 5-9, 2018 • HONG KONG • www.mdscongress.org 13International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Saturday, October 06, 2018
2206 Parallel Session 3. Describe the problems associated with transitioning 2. Describe gait disorders seen in Parkinsonian disorders
from pediatric to adult neurology care and frontal lobe gait disorders
What’s New in Genetics of
3. Describe gait disorders seen in other movement
Movement Disorders 2208 Parallel Session disorders such as ataxia, chorea, and dystonia
15:30 – 17:30 Late Breaking News in
Chairs: Nobutaka Hattori, Japan Movement Disorders 2310 Teaching Course
Baorong Zhang, People’s Republic of China 15:30 – 17:30 Movement Disorders Meets
15:30 Parkinson’s Disease and
Chairs: Michael Okun, USA Psychiatry
Parkinsonism
Ryosuke Takahashi, Japan 15:30 – 17:30
Vincenzo Bonifati, Netherlands
15:30 IPS Cells: An Old and New Chairs: Mark Edwards, United Kingdom
16:10 Hyperkinetic Movement Approach for Understanding and
Disorders Jon Stone, United Kingdom
Treating Movement Disorders?
Carolyn Sue, Australia 15:30 Psychiatric Features in
Ryosuke Takahashi, Japan Movement Disorders
16:50 Genetic Testing in the Next- 16:10 GBA Mutations: A Basis for
Generation Sequencing Era Victor Fung, Australia
Individualized Therapy in
Martha Nance, USA Parkinson’s Disease? 16:10 Functional Movement Disorders
Recommended Audience: Basic scientists, Clinical academicians, Nir Giladi, Israel Mark Edwards, United Kingdom
Non-physician Health Professionals, Practitioners, Students/ 16:50 Can Understanding LRRK2 Lead 16:50 Movement Disorders in
Residents/Trainees
to New Therapies? Psychiatric Patients
At the conclusion of this session, participants should be Chin-Hsien Lin, Taiwan Peter Kempster, Australia
better able to: Recommended Audience: Basic scientists, Clinical academicians, Recommended Audience: Clinical academicians, Non-physician
1. Summarize recently identified genes related to Practitioners, Students/Residents/Trainees Health Professionals, Practitioners, Students/Residents/Trainees
Parkinson’s disease and Parkinsonism At the conclusion of this session, participants should be
At the conclusion of this session, participants should be
2. Summarize recently identified genes related to better able to:
better able to:
dystonia, tremor paroxysmal movement disorders, 1. Recognize the main psychiatric disturbances in
1. Explain the potential role of IPS cells for
and others patients with different movement disorders
understanding and treating Parkinson’s disease
3. Discuss current genetic testing methods for the 2. Discuss the clinical features and psychiatric
2. Identify recent progress in linking GBA mutations to
diagnosis of movement disorders background of functional movement disorders
disease mechanisms and their implication for
treatment trials 3. Describe movement disorders in psychiatric disorders
2207 Parallel Session 3. Describe approaches for disease modifying therapy in including side effects of drugs
Evolution of Movement PD with LRRK2 as target for therapeutic trials
Disorders in the Pediatric 2411 Skills Workshop
Population 2309 Teaching Course Traditional Methods vs.
15:30 – 17:30 Gait Abnormalities in Novel Technologies for
Chairs: Roland Dominic Jamora, Philippines Movement Disorders Assessing Tremor
Yoshiko Nomura, Japan 15:30 – 17:30 18:00 – 19:30
15:30 A Practical Approach to the Chairs: Bastiaan Bloem, Netherlands Dietrich Haubenberger, USA
Diagnosis of Movement Barry Snow, New Zealand Fatta Nahab, USA
Disorders in Children
15:30 How to Examine Gait and Balance Recommended Audience: Basic scientists, Clinical academicians,
Yoshiko Nomura, Japan Non-physician Health Professionals, Practitioners, Students/
John Nutt, USA
16:10 The Spectrum of Childhood Residents/Trainees
16:10 Gait Problems in Parkinsonism
Movement Disorders and Their
and Frontal Lobe Gait Disorders At the conclusion of this session, participants should be
Evolution to Adulthood
Simon Lewis, Australia better able to:
Jennifer Friedman, USA
16:50 Gait Problems in Hyperkinetic 1. Identify new motion sensor systems for analysis,
16:50 Crossing Barriers: Transitioning diagnosis, and assessment of tremor
Movement Disorders
From Pediatric Care to Adult Care 2. Describe the advantages and disadvantages of
Bart Van De Warrenburg, Netherlands
Emmanuel Roze, France technology-based assessments, and estimate its
Recommended Audience: Clinical academicians, Non-physician
Recommended Audience: Basic scientists, Clinical academicians, accuracy and test-re-test reliability
Health Professionals, Practitioners, Students/Residents/Trainees
Practitioners, Students/Residents/Trainees 3. Integrate the classical criteria and new instruments for
At the conclusion of this session, participants should be tremor characterization and assessment
At the conclusion of this session, participants should be
better able to:
better able to:
1. Review the clinical features of normal gait and to
1. Describe a practical approach to the diagnosis of
recognize key abnormalities according to the level of
movement disorders in children
neurological system affected (‘higher, middle, lower
2. Recognize the spectrum of pediatric movement
order gait disorders’)
disorders and their evolution to adulthood
14 October 5-9, 2018 • HONG KONG • www.mdscongress.orgInternational Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Saturday, October 06, 2018
2412 Skills Workshop 2414 Skills Workshop 2517 Video Session
Practical Use of the MDS- Novel Scientific Tools For How to Examine: A
UPDRS: A Global Effort Advancing the Clinician’s Perspective of
18:00 – 19:30 Understanding of Bedside Examination
Vincent Mok, Hong Kong Movement Disorders 18:00 – 19:30
Glenn Stebbins, USA 18:00 – 19:30 Niall Quinn, United Kingdom
Recommended Audience: Basic scientists, Clinical academicians, Tomas Bjorklund, Sweden Stephen Reich, USA
Non-physician Health Professionals, Practitioners, Students/ Alexandra Nelson, USA Recommended Audience: Basic scientists, Clinical academicians,
Residents/Trainees Non-physician Health Professionals, Practitioners, Students/
Recommended Audience: Basic scientists, Clinical academicians,
At the conclusion of this session, participants should be Practitioners, Students/Residents/Trainees Residents/Trainees
better able to: At the conclusion of this session, participants should be At the conclusion of this session, participants should be
1. Apply and interpret the scale in clinical and research better able to: better able to:
settings including available technological advances 1. Describe possible applications of optogenetics and 1. Describe optimal techniques to elicit a comprehensive
including aps and on-line training program chemogenetics to study the pathophysiology of history
2. Practice using the MDS-UPDRS through interactive movement disorders 2. Develop best techniques to elicit an informative
exercises and test cases during the session 2. Define the basic principles of CRISPR/Cas9 examination
3. Recognize the process utilized to develop non-English methodology for editing genomic DNA 3. Develop appropriate reasoning to achieve accurate
official versions of the MDS-UPDRS with special 3. Describe the technical and biological requirements diagnoses
emphasis on available Asian language editions that need to be fulfilled for a fruitful application of the
above technologies 2518 Video Session
2413 Skills Workshop Ataxia
Integrative Medicine and 2515 Video Session 18:00 – 19:30
Multidisciplinary Care Showcases From Asia Orlando Barsottini, Brazil
18:00 – 19:30 18:00 – 19:30 Kinya Ishikawa, Japan
Jennifer Goldman, USA Cid Czarina Diesta, Philippines Recommended Audience: Basic scientists, Clinical academicians,
Alice Nieuwboer, Belgium Shen-Yang Lim, Malaysia
Non-physician Health Professionals, Practitioners, Students/
Recommended Audience: Clinical academicians, Non-physician Residents/Trainees
Recommended Audience: Basic scientists, Clinical academicians,
Health Professionals, Practitioners, Students/Residents/Trainees At the conclusion of this session, participants should be
Non-physician Health Professionals, Practitioners, Students/
At the conclusion of this session, participants should be Residents/Trainees better able to:
better able to: At the conclusion of this session, participants should be 1. Identify clinical features in the differential diagnosis of
1. Identify the value and efficacy of integrated care better able to: acquired, sporadic, and hereditary ataxias
management for different stages of Parkinson’s 1. Recognize hereditary movement disorders which are 2. Review the systematic work up of the ataxias
disease and other common movement disorders more common in Asians 3. Discuss examination strategies to elicit and facilitate
2. Appraise the scientific basis of non-pharmacological 2. Recognize acquired movement disorders which are the diagnosis of ataxia signs and symptoms
interventions of Parkinson’s disease and other related with environment or culture in Asians
common movement disorders 3. Discuss how geographical origin or ethnic background
3. Optimize strategies and logistics to implement can influence differential diagnosis
patient-centered care in movement disorder clinics
2516 Video Session
Unusual Movement
Disorders
18:00 – 19:30
Carlos Cosentino, Peru
Francesca Morgante, Italy
Recommended Audience: Clinical academicians, Non-physician
Health Professionals, Practitioners, Students/Residents/Trainees
At the conclusion of this session, participants should be
better able to:
1. Recognize less common inherited movement disorders
2. Recognize less common acquired or idiopathic
movement disorders
3. Describe an approach to the differential diagnosis of
unusual movement disorders
October 5-9, 2018 • HONG KONG • www.mdscongress.org 15International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Sunday, October 07, 2018
3101 Plenary Session 3203 Parallel Session 3. Define the new developments to improve patient
selection for neuromodulation therapies including
Update on Recent Clinical Advances in Stem Cells and
imaging, biomarkers and genetics
Trials Parkinson’s Disease
8:00 – 9:30 15:30 – 17:30 3205 Parallel Session
Chairs: Carolyn Sue, Australia Chairs: Dimitri Krainc, USA
Louis Tan, Singapore Ken Yung, Hong Kong Visual Hallucinations in
8:00 Update on Clinical Trials in 15:30 Human Stem Cells: Options Parkinson’s Disease and
Parkinson’s Disease: Motor Available Lewy Body Dementias: From
Thomas Foltynie, United Kingdom Jeffrey Kordower, USA Mechanism to Management
8:30 Update on Clinical Trials in 16:10 Modeling Pathogenesis of 15:30 – 17:30
Parkinson’s Disease: Non-Motor Parkinson’s Disease Chairs: Jennifer Goldman, USA
Karen Marder, USA Dimitri Krainc, USA Daniel Weintraub, USA
9:00 Update on Clinical Trials in 16:50 Stem Cells for Therapeutics: 15:30 Current Theories on Visual
Atypical Parkinsonian Disorders Fantasy or Reality? Hallucinations
Wassilios Meissner, France Anne Rosser, United Kingdom John-Paul Taylor, United Kingdom
Recommended Audience: Basic scientists, Clinical academicians, Recommended Audience: Basic scientists, Clinical academicians, 16:10 Neuroimaging and Visual
Non-physician Health Professionals, Practitioners, Students/ Non-physician Health Professionals, Practitioners, Students/ Hallucinations: A Window Into
Residents/Trainees Residents/Trainees Their Mechanism
At the conclusion of this session, participants should be At the conclusion of this session, participants should be Javier Pagonabarraga, Spain
better able to: better able to: 16:50 Management Strategies for
1. Discuss recent clinical trials in Parkinson’s disease 1. Describe the history and technological advances in Visual Hallucinations
2. Review recent clinical trials for non-motor features of stem cell biology Daniel Weintraub, USA
Parkinson’s disease 2. Explain how stem cells can be used to study the Recommended Audience: Basic scientists, Clinical academicians,
3. Discuss recent clinical trials for atypical parkinsonian pathogenesis of Parkinson’s disease Non-physician Health Professionals, Practitioners, Students/
disorders 3. Discuss the current status of stem cell therapy Residents/Trainees
including challenges and pitfalls At the conclusion of this session, participants should be
3102 Plenary Session better able to:
Grand Rounds 3204 Parallel Session 1. Discuss current theories of visual hallucinations in
10:30 – 12:30 Parkinson’s disease and Lewy body dementias
Technologies to Advance
2. Describe neuroimaging findings associated with visual
Chairs: Mandy Au Yeung, Hong Kong Neuromodulation Therapy hallucinations in Parkinson’s disease and Lewy body
Yuk-Fai Nelson Cheung, Hong Kong for Movement Disorders dementias
Vincent Mok, Hong Kong 15:30 – 17:30 3. Review management strategies for visual
MDS Experts: Kailash Bhatia, United Kingdom Chairs: Volker Coenen, Germany hallucinations in Parkinson’s disease and Lewy body
Susan Fox, Canada Takaomi Taira, Japan dementias
Yoshikuni Mizuno, Japan
Mayela Rodriguez Violante, Mexico 15:30 New Engineering Technologies
Recommended Audience: Basic scientists, Clinical academicians,
Alberto Priori, Italy
Non-physician Health Professionals, Practitioners, Students/ 16:10 New Surgical Strategies
Residents/Trainees Volker Coenen, Germany
At the conclusion of this session, participants should be 16:50 New Technologies for Patient
better able to: Selection
1. Identify how experts use the clinical history and exam Maria Contarino, Netherlands
to formulate their diagnosis in movement disorders Recommended Audience: Basic scientists, Clinical academicians,
cases Non-physician Health Professionals, Practitioners, Students/
Residents/Trainees
2. Identify how experts use diagnostic testing in the
differential diagnosis of movement disorders At the conclusion of this session, participants should be
3. Identify how experts plan therapies for movement better able to:
disorder patients 1. Describe the most recent advances in
neuromodulation technologies including closed loop
and adaptive stimulation and steerable electrodes
2. Compare emerging trends in surgical strategies
including intraoperative imaging, local field
potentials, or networks
16 October 5-9, 2018 • HONG KONG • www.mdscongress.orgInternational Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Sunday, October 07, 2018
3206 Parallel Session 3208 Parallel Session At the conclusion of this session, participants should be
better able to:
Prodromal Parkinson’s Understanding and
1. Describe novel technologies that may be applied to
Disease Managing Complex Gait diagnosis of movement disorders
15:30 – 17:30 Disorders in Parkinson’s 2. Discuss the future use of wearable technology and
Chairs: Daniela Berg, Germany Disease web-based applications
Etienne Hirsch, France 15:30 – 17:30 3. Explain machine learning approaches for large data
15:30 Clinical, Genetic, and Imaging Chairs: Nir Giladi, Israel analyses
Features Alice Nieuwboer, Belgium
Daniela Berg, Germany 15:30 The Interplay Between Walking 3310 Teaching Course
16:10 Understanding the Biological Ability and Cognitive Function Update on Huntington’s
Basis of Prodromal Parkinson’s Lynn Rochester, United Kingdom
Disease Disease and Other Choreas
16:10 Complex Gait and Postural 15:30 – 17:30
Etienne Hirsch, France Instability: A Balancing Act?
16:50 The Future: How to Modify the Chairs: Emilia Gatto, Argentina
Colum MacKinnon, USA
Course of Parkinson’s Disease Hui Fang Shang, People’s Republic of China
16:50 Assessment and Therapeutic
Jean-Christophe Corvol, France 15:30 Huntington’s Disease Clinical
Options for Complex Gait
Recognition and Differential
Recommended Audience: Basic scientists, Clinical academicians, Disorders: A Contemporary View
Non-physician Health Professionals, Practitioners, Students/
Diagnosis of Choreas
Bastiaan Bloem, Netherlands
Residents/Trainees Hui Fang Shang, People’s Republic of China
Recommended Audience: Clinical academicians, Non-physician
16:10 Current Concepts of
At the conclusion of this session, participants should be Health Professionals, Practitioners, Students/Residents/Trainees
Huntington’s Disease
better able to: At the conclusion of this session, participants should be Pathogenesis
1. Identify clinical genetic and imaging features for better able to: Alexandra Durr, France
prodromal Parkinson’s disease 1. Recognize how prefrontal dysfunction impacts on 16:50 Symptomatic and Disease
2. Explain the pathophysiological basis for prodromal complex walking ability Modifying Treatments for Chorea
Parkinson’s disease 2. Identify the locomotor-brainstem network and Huntington’s Disease
3. Discuss future clinical trial design and strategies for abnormalities underlying gait disorders Hitoshi Okazawa, Japan
disease modification 3. Discuss management strategies which target the Recommended Audience: Clinical academicians, Non-physician
complexity of gait deficits Health Professionals, Practitioners, Students/Residents/Trainees
3207 Parallel Session
At the conclusion of this session, participants should be
Challenges in Clinicogenetic 3309 Teaching Course better able to:
Correlations: One Gene – Wearable Technology and 1. Recognize the clinical features of Huntington’s disease
Many Phenotypes; One Machine Learning for subtypes and generate a classification-oriented
Phenotype – Many Genes Quantitative Evaluation of differential diagnosis
15:30 – 17:30 Parkinson’s Disease 2. Discuss disease mechanisms and genetic modifiers for
Chairs: Vincenzo Bonifati, Netherlands Huntington’s disease
15:30 – 17:30
Hyder Jinnah, USA 3. Describe symptomatic therapies for chorea and
Chairs: Roongroj Bhidayasiri, Thailand emerging strategies to address Huntington’s disease
15:30 One Gene – Many Phenotypes Alberto Espay, USA
Roberto Erro, Italy progression
15:30 Wearable Sensors and Smart
16:10 One Phenotype – Many Genes Phones: Can They Be Diagnostic
Marialuisa Quadri, Netherlands Tools?
16:50 Clinical Implications – Diagnosis Alberto Espay, USA
and Management Strategies 16:10 Machine Learning and Large-
Eng King Tan, Singapore Scale Sensor-Based Analysis for
Recommended Audience: Basic scientists, Clinical academicians, Parkinson’s Disease
Non-physician Health Professionals, Practitioners, Students/ Bjoern Eskofier, Germany
Residents/Trainees 16:50 Wearable Technology for
At the conclusion of this session, participants should be Monitoring Patients at Home
better able to: Roongroj Bhidayasiri, Thailand
1. Recognize the sometimes different and complex Recommended Audience: Basic scientists, Clinical academicians,
phenotypes of monogenic mutations Non-physician Health Professionals, Students/Residents/Trainees
2. Recognize similar clinical phenotypes resulting from
different genetic mutations
3. Discuss the evolving role of genetics in the diagnosis
and management of movement disorders
October 5-9, 2018 • HONG KONG • www.mdscongress.org 17International Congress of Parkinson’s Disease and Movement Disorders®
Preliminary Program
Sunday, October 07, 2018
3411 Skills Workshop 3. Recognize more challenging cases and how to deal 3. Outline areas of ongoing uncertainty in the differential
with them diagnosis of various tremors
Urogenital Dysfunction in
Parkinson’s Disease
3414 Skills Workshop 3417 Skills Workshop
18:00 – 19:30
Onanong Jitkritsadakul, Thailand
Lessons from My Patients Challenges in Movement
Jalesh Panicker, United Kingdom 18:00 – 19:30 Disorders Education: A
Recommended Audience: Basic scientists, Clinical academicians, Cynthia Comella, USA Comparison of Africa and
Non-physician Health Professionals, Practitioners, Students/ Oscar Gershanik, Argentina Asia
Residents/Trainees Philip Thompson, Australia 18:00 – 19:30
Recommended Audience: Basic scientists, Clinical academicians, Njideka Okubadejo, Nigeria
At the conclusion of this session, participants should be
Non-physician Health Professionals, Practitioners, Students/
better able to: Louis Tan, Singapore
Residents/Trainees
1. Identify the basis of bladder and sexual dysfunction in Recommended Audience: Clinical academicians, Non-physician
Parkinson’s disease At the conclusion of this session, participants should be Health Professionals, Practitioners, Students/Residents/Trainees
2. Recognize the impact of bladder and sexual better able to:
At the conclusion of this session, participants should be
dysfunction on quality of life for patient and partner 1. Critique pertinent clinical history and examinations
better able to:
3. Determine evidence-based and state-of-the-art when diagnosis and management are in doubt
1. Describe the current and past movement disorder
management strategies for bladder and sexual 2. Interpret key features and construct appropriate
educational activities taking place in Sub-Saharan
dysfunction in Parkinson’s disease diagnostic and management strategies
Africa
3. Identify common pitfalls in the evaluation of
3412 Skills Workshop 2. Describe the current and past movement disorder
movement disorders
educational activities taking place in Asia
Atypical Parkinson 3. Identify the potential strategies for enhancing
Disorders: Multiple System 3415 Skills Workshop movement disorder training in different parts of the
Atrophy and Corticobasal Rare Autoimmune and world
Degeneration / Progressive Infectious Movement
Supranuclear Palsy Disorders Not to Miss 3518 Video Session
18:00 – 19:30 18:00 – 19:30 Eye Movements
Han-Joon Kim, South Korea Bettina Balint, United Kingdom 18:00 – 19:30
Maria Stamelou, Greece Mohit Bhatt, India Ji-Soo Kim, South Korea
Recommended Audience: Clinical academicians, Non-physician Recommended Audience: Basic scientists, Clinical academicians, Aasef Shaikh, USA
Health Professionals, Practitioners, Students/Residents/Trainees Non-physician Health Professionals, Practitioners, Students/
Recommended Audience: Clinical academicians, Non-physician
Residents/Trainees
At the conclusion of this session, participants should be Health Professionals, Practitioners, Students/Residents/Trainees
better able to: At the conclusion of this session, participants should be At the conclusion of this session, participants should be
1. Distinguish atypical Parkinsonian disorders based on better able to: better able to:
clinical features 1. Recognize autoimmune and infectious rare movement 1. Apply bedside examination of eye movements for the
2. Discuss ancillary investigations for the diagnosis of disorders differential diagnosis of movement disorders
atypical Parkinsonian disorders 2. Discuss diagnostic tests for autoimmune and 2. Identify typical eye movement abnormalities of
3. Describe therapeutic options for atypical Parkinsonian infectious rare movement disorders fixation, saccades, pursuit, vergence and vestibular
disorders 3. Describe therapeutic options for autoimmune and function
infectious rare movement disorders 3. Recognize characteristic eye movement abnormalities
3413 Skills Workshop in movement disorders
Botulinum Toxins
3416 Skills Workshop
18:00 – 19:30 Tremor Update
Ryuji Kaji, Japan 18:00 – 19:30
Erle Chuen-Hian Lim, Singapore Günther Deuschl, Germany
Recommended Audience: Clinical academicians, Non-physician Rodger Elble, USA
Health Professionals, Practitioners, Students/Residents/Trainees Recommended Audience: Basic scientists, Clinical academicians,
Non-physician Health Professionals, Practitioners, Students/
At the conclusion of this session, participants should be Residents/Trainees
better able to:
1. Summarize the importance of accurate diagnosis and At the conclusion of this session, participants should be
clinical examination of muscle patterns involved for better able to:
optimal BoNT treatment of movement disorders 1. Summarize the history and evolution of the term
2. Apply state-of-the-art BoNT procedures for focal “essential tremor”
dystonias, spasticity and other disorders 2. Describe the recently proposed changes in the
definitions and classifications of all tremors
18 October 5-9, 2018 • HONG KONG • www.mdscongress.orgYou can also read
